John B Green - Net Worth and Insider Trading
John B Green Net Worth
The estimated net worth of John B Green is at least $771,046 dollars as of 2024-05-08. John B Green is the CFO of Dicerna Pharmaceuticals Inc and owns about 19,421 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $742,271. John B Green is also the CFO of Verastem Inc and owns about 2,500 shares of Verastem Inc (VSTM) stock worth over $28,775. Details can be seen in John B Green's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John B Green has not made any transactions after 2020-04-20 and currently still holds the listed stock(s).
Transaction Summary of John B Green
John B Green Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John B Green owns 2 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , and Verastem Inc (VSTM) .
Click here to see the complete history of John B Green’s form 4 insider trades.
Insider Ownership Summary of John B Green
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-04-20 | Chief Financial Officer |
| VSTM | Verastem Inc | 2015-06-29 | Chief Financial Officer |
John B Green Latest Holdings Summary
John B Green currently owns a total of 2 stocks. Among these stocks, John B Green owns 19,421 shares of Dicerna Pharmaceuticals Inc (DRNA) as of April 20, 2020, with a value of $742,271 and a weighting of 96.27%. John B Green also owns 2,500 shares of Verastem Inc (VSTM) as of June 29, 2015, with a value of $28,775 and a weighting of 3.73%.
Latest Holdings of John B Green
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2020-04-20 | 19,421 | 38.22 | 742,271 |
| VSTM | Verastem Inc | 2015-06-29 | 2,500 | 11.51 | 28,775 |
Holding Weightings of John B Green
John B Green Form 4 Trading Tracker
According to the SEC Form 4 filings, John B Green has made a total of 7 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 25,624 shares on April 20, 2020, which brought John B Green around $588,071.
According to the SEC Form 4 filings, John B Green has made a total of 0 transactions in Verastem Inc (VSTM) over the past 5 years. The most-recent trade in Verastem Inc is the acquisition of 500 shares on June 29, 2015, which cost John B Green around $3,560.
Insider Trading History of John B Green
- 1
John B Green Trading Performance
GuruFocus tracks the stock performance after each of John B Green's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John B Green is -48.14%. GuruFocus also compares John B Green's trading performance to market benchmark return within the same time period. The performance of stocks bought by John B Green within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John B Green's insider trading performs compared to the benchmark.
Performance of John B Green
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.43 | | | | | |
| Relative Return to S&P 500(%) | 1.71 | | | | | |
John B Green Ownership Network
John B Green Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
John B Green is the Chief Financial Officer of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
John B Green Mailing Address
Above is the net worth, insider trading, and ownership report for John B Green. You might contact John B Green via mailing address: C/o Dicerna Pharmaceuticals, Inc., 33 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
